FDA says CBD not recognized as safe in food, warns manufacturers
FDA cites 15 companies making unsubstantiated claims.
Read more
 
Physicians' group wants drug price transparency
PBM mergers contribute to pricing problems, ACP says.
Read more
 
Breakthrough therapies, opportunities for savings in near-term specialty pipeline
From our sister publication, Managed Healthcare Executive®: As more competition makes its way into the specialty drug market, there will be opportunities for cost savings.
Read more